Kymera Therapeutics, Inc.

Invesco Ltd. KYMR
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/12/2026
Shares
110,415
Value ($000)
9,196
Weight
0.0%
2021 Q2 - 2026 Q1 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).